<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Cancer":5,
"Metastasis":4,
"SOX family":1,
"Targets":1,
"Tumorigenesis":2,
"Parathyroid carcinoma":2,
"hyperparathyroidism":1,
"surgery":2,
"thyroidectomie intrathyroidal":1,
"HGOS":1,
"Osteosarcoma":1,
"apoptosis":4,
"chemotherapy":1,
"invasion":2,
"secretory clusterin (sCLU)":1,
"benign cold thyroid nodules":1,
"metastatic lymph nodes":1,
"papillary thyroid carcinoma":21,
"single-fiber laser ablation":1,
"ultrasound guidance":1,
"anti-PIT-1 antibody syndrome":1,
"anti-PIT-1 hypophysitis":1,
"autoimmunity":1,
"ectopic expression":1,
"isolated ACTH deficiency":1,
"paraneoplastic syndrome":1,
"pituitary":2,
"thymoma":1,
"adrenal":1,
"glands":1,
"metastases":1,
"ovaries":1,
"thyroid":7,
"Hippo signalling pathway":1,
"STK4":1,
"long non-coding RNA TNRC6C-AS1":1,
"methylation":1,
"thyroid carcinoma":7,
"Cancer biomarker":1,
"Early diagnosis":1,
"Free fatty acids":1,
"Malignant neoplasm":1,
"Transoral endoscopic selective lateral neck dissection":1,
"Transoral thyroidectomy":1,
"CTLA-4 inhibitor":1,
"Immune ﻿checkpoint ﻿inhibitors":1,
"PD-1 inhibitor":1,
"adrenal insufficiency":1,
"diabetes":1,
"hyperthyroidism":1,
"hypoparathyroidism":2,
"hypophysitis":2,
"hypothyroidism":2,
"ipilimumab":1,
"nivolumab":1,
"PI3K/AKT signalling pathway":1,
"Papillary thyroid cancer":2,
"Wnt/β-catenin signalling pathway":1,
"lncRNA highly up-regulated in liver cancer":1,
"microRNA-106a":1,
"Chemosensitivity":1,
"Oral squamous cell carcinoma":1,
"TGF-β1":1,
"miR-132":1,
"BRAF(V600E)":1,
"HBME-1":1,
"Lymph node metastasis":4,
"Ultrasound":3,
"SI-2":1,
"anaplastic thyroid carcinoma":3,
"cancer stem-like cells":1,
"small-molecule inhibitor":1,
"steroid receptor coactivator-3":1,
"Anaplastic thyroid cancer genomics":1,
"BRAF":2,
"Next generation sequencing":1,
"RAS":2,
"Critical transition":1,
"Dynamic network biomarker (DNB)":1,
"Pre-disease state":1,
"Single-sample Kullback–Leibler divergence (sKLD)":1,
"Tipping point":1,
"carcinoma":1,
"mutation":1,
"prognosis":7,
"thyroid neoplasms":4,
"Calretinin":1,
"EGFR":1,
"Lung cancer":1,
"Mesothelial markers":1,
"Smoking":1,
"TTF-1":1,
"claudin-4":1,
"core needle biopsy":1,
"fine-needle aspiration":1,
"follicular thyroid carcinoma":1,
"thyroid neoplasm":2,
"ultrasonography":2,
"Palladia":1,
"dog":1,
"neuroendocrine":1,
"outcome":1,
"tyrosine kinase inhibitor":2,
"ANTIRESORPTIVES":1,
"BONE QCT/UCT":1,
"PARATHYROID‐RELATED DISORDERS":1,
"RADIOLOGY":1,
"TUMOR‐INDUCED BONE DISEASE":1,
"Ablative therapies":1,
"Interventional ultrasound":1,
"Radiofrequency ablation":1,
"Epidermal growth factor receptor":1,
"Turkish population":1,
"napsin A":1,
"non-small cell lung cancer":1,
"thyroid transcription factor-1":2,
"High-intensity focused ultrasound ablation":1,
"meta-analysis":2,
"thyroid nodule":2,
"treatment outcome":1,
"inflammation-based scores":1,
"WT1":1,
"breast neoplasms":2,
"carcinogenesis":1,
"Epidemiology":2,
"Gender":1,
"Levothyroxine":1,
"adolescent and young adult":1,
"cancer survivors":1,
"health services utilization":1,
"medical imaging":1,
"pediatric":1,
"Lymph nodes posterior to the right recurrent laryngeal nerve metastasis":1,
"Epidemiological data":1,
"Iodine status":1,
"Thyroid autoimmunity":1,
"Thyroid dysfunction":1,
"Thyroid nodules":2,
"PDOX":1,
"TNBC":1,
"eribulin":1,
"matrix-producing breast carcinoma":1,
"nude mice":1,
"olaparib":1,
"patient-derived orthotopic xenograft":1,
"regression":1,
"resistance":1,
"triple-negative breast cancer":2,
"breast cancer":2,
"diagnostics":1,
"tumour angiogenesis":1,
"tumour markers":1,
"Computed tomography":1,
"Head and neck imaging":1,
"Laryngeal cancer":1,
"Tumour staging":1,
"Addison’s disease":1,
"Autoimmune polyglandular syndrome":1,
"Medullary thyroid cancer":4,
"Multiple endocrine neoplasia":1,
"Pheochromocytoma":1,
"lymph node metastasis (LNM)":1,
"papillary thyroid carcinoma (PTC)":1,
"prognostic factor":2,
"risk factor":1,
"kidney":1,
"renal cell carcinoma":3,
"thyroid-like follicular carcinoma":1,
"miR-486-3p":1,
"myeloid-derived suppressor cells":1,
"tumor invasion":1,
"DICER1":1,
"Germ cell tumor":1,
"Head and neck":1,
"Malignant teratoma":1,
"Rhabdomyosarcoma":1,
"Teratocarcinosarcoma":1,
"Thyroblastoma":1,
"Initial Management":1,
"Lobectomy":2,
"Low Risk":2,
"Risk Factors":4,
"Total Thyriodectomy":1,
"Au@TiO2":1,
"CPT-11":1,
"anti-metastasis":1,
"thyroid cancer":11,
"Calcitonin":1,
"Follicular lesion":1,
"In situ hybridization":1,
"Medullary thyroid carcinoma":3,
"Mixed medullary and follicular thyroid carcinoma":1,
"Cardiac metastasis":1,
"Gastric metastasis":1,
"Lung neoplasms":1,
"Non-bacterial thrombotic endocarditis":1,
"Stroke":1,
"Coexitent tumors":1,
"Mixed tumor":1,
"Multiodular goiter":1,
"Papillary carcinoma":2,
"sarcomatoid":1,
"thyroid-like follicular carcinoma of the kidney":1,
"Asociación":1,
"Carcinoma papilar de tiroides":1,
"Chronic lymphocytic thyroiditis":1,
"Estudio retrospectivo":1,
"Exámenes quirúrgicos":1,
"Retrospective study":2,
"Surgical specimen":1,
"Tiroiditis linfocítica crónica":1,
"Gemcitabine prodrug":1,
"single polymeric nanoparticles":1,
"Genetic syndromes with increased risk of cancer":1,
"Long-term childhood cancer survivors":1,
"Subsequent benign neoplasm":1,
"Subsequent malignant neoplasm":1,
"Subsequent non-melanoma skin cancer":1,
"Continuous neuromonitoring":1,
"Oncocytic carcinoma":1,
"Oncological indications":1,
"Thyroid cancer guidelines":1,
"Anti-CTLA-4":1,
"Anti-PD-1":1,
"Immunotherapy":1,
"Survival":4,
"cytology":3,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"risk of malignancy (ROM)":1,
"risk of neoplasm":1,
"the Bethesda system for reporting thyroid cytopathology (TBSRTC)":1,
"BRAF mutation":3,
"recurrence":3,
"Adjuvant treatment options":1,
"Interdisciplinary treatment concept":1,
"Risk profile":1,
"Side effects":1,
"Storz professional image enhancement system":1,
"cordectomy":1,
"gas":1,
"laryngeal neoplasms":1,
"lasers":1,
"narrow band imaging":1,
"saline infusion":1,
"squamous intraepithelial lesions":1,
"stroboscopy":1,
"transoral":1,
"bronchoalveolar lavage":1,
"exfoliative cytology":1,
"fungal infection":1,
"malignancy":1,
"pneumocystis":1,
"pulmonary infections":1,
"tuberculosis":1,
"Anastomosis establishment":1,
"Differentiated thyroid cancer":1,
"Locally advanced cancer":1,
"Surgical technique":1,
"Thyroid gland":3,
"Active surveillance":2,
"Thyroidectomy":4,
"glucose transporter 1":1,
"glucose uptake":1,
"microRNA-125b":1,
"B-Raf proto-oncogene mutation":1,
"clinicopathological features of papillary thyroid carcinoma":1,
"mutations in telomerase reverse transcriptase promoter":1,
"Diagnostic criteria":1,
"Histology":1,
"Molecular pathology":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"WHO classification":1,
"Bioinformatics":1,
"Colon cancer":1,
"Gene expression":1,
"PLAC1":1,
"Signaling pathways":1,
"Observation":1,
"Papillary thyroid microcarcinoma":1,
"Bone marrow mesenchymal stem cells":1,
"DPP4":1,
"Exosome":1,
"microRNA-152":1,
"AKT3":1,
"circ_0000144":1,
"miR-217":1,
"Esophageal lesion":1,
"Nerve lesions":1,
"Pleural lesion":1,
"Postoperative hemorrhage":1,
"Neoplasms, multiple primary":1,
"Neoplasms, second primary":1,
"Cysteine cathepsins":1,
"Non-canonical trafficking":1,
"Nuclear forms":1,
"Proliferation-promoting":1,
"Cytokeratin 7":1,
"lung adenocarcinoma":1,
"Activating transcription factor 3":1,
"Ferroptosis":1,
"Heat shock protein family B member 1":1,
"Hepatocellular carcinoma":3,
"Overall survival":1,
"Carcinoma papilífero":1,
"Câncer de tireoide":1,
"Mutação em BRAF":1,
"Prognóstico":1,
"Recorrência":1,
"Sobrevida":1,
"Adenocarcinoma, follicular":1,
"World Health Organization":1,
"lymph node dissection":1,
"microcarcinoma":1,
"anaplastic thyroid cancer":1,
"lenvatinib":2,
"NIFTP":1,
"descriptive trends":1,
"incidence":1,
"overdiagnosis":1,
"Diet":1,
"Food items":1,
"Breach of the thyroid capsule":1,
"Calcitonin determination":1,
"Desmoplasia":1,
"Frozen section":1,
"Limited resection":1,
"CTLA-4":1,
"Immune co-inhibitory receptors":1,
"PD-1":1,
"PD-L1":1,
"TIM-3":1,
"CCNA1 gene":1,
"Cyclin A1":1,
"Diagnostic":1,
"Molecular marker":1,
"Protein expression":1,
"Advanced differentiated thyroid carcinoma":1,
"Multi-kinase inhibitors":1,
"Radioiodine-refractory thyroid carcinoma":1,
"Selective treatment":1,
"central nervous system neoplasms":1,
"childhood cancer survivor":1,
"hypopituitarism":1,
"radiotherapy":2,
"DICER1 syndrome":1,
"Multinodular goitre":1,
"Poorly differentiated thyroid cancer":1,
"adverse events":1,
"Open surgery":1,
"Robotic surgery":1,
"Barriers":1,
"Neoplasms":1,
"Oman":1,
"colorectal":1,
"early detection":1,
"RET":1,
"molecular prognostic factors":1,
"transcriptome":1,
"adjuvant therapy":1,
"clinical features":1,
"differentiated thyroid carcinoma":1,
"postoperative survival":1,
"prognostic factors":1,
"spinal metastasis":1,
"surgical treatment":1,
"endocrine cancer":1,
"head and neck cancer":2,
"cell cycle arrest":1,
"human rhabdomyosarcoma RD cells":1,
"pseudolaric acid B":1,
"Chernobyl":2,
"Fukushima":1,
"age-matched groups":1,
"pathology":1,
"indeterminate thyroid cytology":1,
"nuclear atypia":1,
"Endogenous control":1,
"FFPE":1,
"Stability":1,
"miRNA":1,
"DNMT3A":1,
"germline variant":1,
"paraganglioma":1,
"microRNA-623":1,
"migration":1,
"proliferation":1,
"calcitonin (Ctn)":1,
"carcinoembryonic antigen (CEA)":1,
"management":1,
"medullary thyroid carcinoma (MTC)":1,
"Ectopic thyroid tissue":1,
"adrenal gland":1,
"case report":1,
"Cancer immunity":1,
"Diagnostic biomarker":1,
"IL-1":1,
"IL1RN":1,
"Prognostic biomarker":1,
"Metachronous carcinoma":1,
"Radiation":1,
"Second malignancy":1,
"Long noncoding RNAs":1,
"MIR22HG":1,
"Therapeutic target":1,
"MTC":1,
"MTC detection":1,
"optimal surgery":1,
"preoperative diagnosis":1,
"Hurthle cell tumor":1,
"otolaryngology":1,
"pediatric thyroid mass":1,
"thyroid mass":1,
"PGC1α":1,
"ROS":1,
"progression":1,
"Radiomic analysis":1,
"18F":1,
"18F-NaF":1,
"Bone metastases":1,
"Fluorine":1,
"PET/CT":1,
"BMI":1,
"BMI-gene interaction":1,
"FTO":1,
"Obesity":1,
"Assay interference":1,
"Heterophilic antibody":1,
"Thyroid stimulating hormone":1,
"aldehyde dehydrogenase 1":1,
"microarray analysis":1,
"network analysis":1,
"5hmC":1,
"IDH1":1,
"TROP-2":1,
"anaplastic carcinoma":1,
"TCGA":1,
"copy number variation":1,
"telomerase":1,
"ablation":1,
"laser":1,
"lymph node":1,
"metastatic":1,
"papillary":1,
"Nodular goiter":1,
"Polycyclic aromatic hydrocarbon":1,
"Risk assessment":1,
"COVID-19":1,
"Google Trends":1,
"digital epidemiology":1,
"internet search":1,
"oculofacial plastic surgery":1,
"Case report, thyroid, sarcomatoid differentiation":1,
"Parathyroid":1,
"Sacroma":1,
"ear":1,
"nose and throat/otolaryngology":1,
"diagnosis":1,
"magnetic resonance imaging":1,
"neoplasm staging":1,
"radiomics":1,
"131iodine":1,
"drug delivery":1,
"p53 mutants":1,
"radiogenetic dual therapy":1,
"Artificial intelligence":1,
"Machine learning":1,
"Thyroid fine needle aspiration biopsy":1,
"cyclooxygenase-2":1,
"disease-free survival":1,
"Radiation induced cancer":1,
"hormone therapy":1,
"multidisciplinary management":1,
"particle therapy":1,
"salivary gland cancer":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年12月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
